GCA
EXEL icon

Greenwood Capital Associates’s Exelixis EXEL Stock Holding History

Greenwood Capital Associates’s Portfolio EXEL Stock Details EXEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$444K Sell
8,152
-295
-3% -$14.4K 0.04% 232
2026
Q1 		$362K Sell
8,447
-416
-5% -$17.9K 0.04% 244
2025
Q4 		$388K Sell
8,863
-826
-9% -$34.2K 0.04% 219
2025
Q3 		$400K Buy
+9,689
New +$389K 0.05% 207

Other funds holding EXEL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Greenwood Capital Associates's EXEL Position: Q2 2026 in Review

Greenwood Capital Associates reduced its Exelixis (EXEL) stake by 3.5% in Q2 2026, selling an estimated $14.4K and leaving 8,152 shares worth $444K. The position accounts for 0.04% of the portfolio, ranked #232.

Greenwood Capital Associates first reported a position in EXEL in Q3 2025 and has held it in 4 quarters since. 760 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Greenwood Capital Associates held 8,152 shares of Exelixis worth $444K as of Q2 2026.
  • Greenwood Capital Associates sold 295 Exelixis shares in Q2 2026, an estimated $14.4K.
  • Exelixis made up 0.04% of Greenwood Capital Associates's portfolio in Q2 2026, its #232 holding.
  • Greenwood Capital Associates first reported a position in Exelixis in Q3 2025 and has held it in 4 quarters since.
  • 760 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Greenwood Capital Associates's 13F filing for Q2 2026, filed 28 Jul 2026.